{"id":"https://openalex.org/W2048910098","doi":"https://doi.org/10.1038/sj.bjp.0705059","title":"The anti\u2010relapse compound acamprosate inhibits the development of a conditioned place preference to ethanol and cocaine but not morphine","display_name":"The anti\u2010relapse compound acamprosate inhibits the development of a conditioned place preference to ethanol and cocaine but not morphine","alternate_titles":[],"publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W2048910098","doi":"https://doi.org/10.1038/sj.bjp.0705059","mag":"2048910098","pmid":"https://pubmed.ncbi.nlm.nih.gov/12522067","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1573657"},"language":"en","primary_location":{"id":"doi:10.1038/sj.bjp.0705059","doi":"https://doi.org/10.1038/sj.bjp.0705059","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0705059","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0705059","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2048910098"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0705059","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111567138","display_name":"Andrew McGeehan","orcid":"https://orcid.org/0009-0004-4998-3244","observed_orcids":["https://orcid.org/0009-0004-4998-3244"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210157818","display_name":"Ernest Gallo Clinic and Research Center","ror":"https://ror.org/04g7y4303","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210157818"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andrew J Mcgeehan","raw_affiliation_strings":["Ernest Gallo Clinic and Research Center, Department of Neurology, University of California at San Francisco, 5858 Horton Street, Emeryville, CA 94608, U.S.A","Ernest Gallo Clinic and Research Center, Department of Neurology, University of California at San Francisco, Emeryville, California, CA 94608, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ernest Gallo Clinic and Research Center, Department of Neurology, University of California at San Francisco, 5858 Horton Street, Emeryville, CA 94608, U.S.A","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210157818"]},{"raw_affiliation_string":"Ernest Gallo Clinic and Research Center, Department of Neurology, University of California at San Francisco, Emeryville, California, CA 94608, U.S.A","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210157818"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076836999","display_name":"Michael Foster Olive","orcid":"https://orcid.org/0000-0002-2517-0351","observed_orcids":["https://orcid.org/0000-0002-2517-0351"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210157818","display_name":"Ernest Gallo Clinic and Research Center","ror":"https://ror.org/04g7y4303","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210157818"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"M Foster Olive","raw_affiliation_strings":["Ernest Gallo Clinic and Research Center, Department of Neurology, University of California at San Francisco, Emeryville, California, CA 94608, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ernest Gallo Clinic and Research Center, Department of Neurology, University of California at San Francisco, Emeryville, California, CA 94608, U.S.A","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210157818"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5076836999"],"corresponding_institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210157818"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":1.8031,"has_fulltext":true,"cited_by_count":82,"citation_normalized_percentile":{"value":0.83762492,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"138","issue":"1","first_page":"9","last_page":"12"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9603999853134155,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9603999853134155,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.029600000008940697,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acamprosate","display_name":"acamprosate","score":1.0},{"id":"https://openalex.org/keywords/conditioned-place-preference","display_name":"conditioned place preference","score":0.8489999771118164},{"id":"https://openalex.org/keywords/ethanol","display_name":"ethanol","score":0.7409999966621399},{"id":"https://openalex.org/keywords/cocaine","display_name":"cocaine","score":1.0},{"id":"https://openalex.org/keywords/morphine","display_name":"morphine","score":1.0},{"id":"https://openalex.org/keywords/drug-reward","display_name":"drug reward","score":0.6430000066757202},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.7580000162124634},{"id":"https://openalex.org/keywords/addiction","display_name":"addiction","score":0.3230000138282776},{"id":"https://openalex.org/keywords/conditioned-aversion","display_name":"conditioned aversion","score":0.6620000004768372}],"concepts":[{"id":"https://openalex.org/C2779992327","wikidata":"https://www.wikidata.org/wiki/Q337668","display_name":"Acamprosate","level":5,"score":0.9561501741409302},{"id":"https://openalex.org/C35124327","wikidata":"https://www.wikidata.org/wiki/Q5159285","display_name":"Conditioned place preference","level":3,"score":0.9068827629089355},{"id":"https://openalex.org/C45262634","wikidata":"https://www.wikidata.org/wiki/Q5159291","display_name":"Conditioning","level":2,"score":0.7602133750915527},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.7449097633361816},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6668282151222229},{"id":"https://openalex.org/C2780161600","wikidata":"https://www.wikidata.org/wiki/Q153","display_name":"Ethanol","level":2,"score":0.6388684511184692},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4589662551879883},{"id":"https://openalex.org/C2777397205","wikidata":"https://www.wikidata.org/wiki/Q275792","display_name":"Saline","level":2,"score":0.4412948787212372},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.335407018661499},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.2958764433860779},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.28039294481277466},{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.2489807903766632},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.1719488799571991},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11626240611076355},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0773463249206543},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077443","descriptor_name":"Acamprosate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000427","descriptor_name":"Alcohol Deterrents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000431","descriptor_name":"Ethanol","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D000431","descriptor_name":"Ethanol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003042","descriptor_name":"Cocaine","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D003042","descriptor_name":"Cocaine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003216","descriptor_name":"Conditioning, Operant","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003216","descriptor_name":"Conditioning, Operant","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008811","descriptor_name":"Mice, Inbred DBA","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009020","descriptor_name":"Morphine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013654","descriptor_name":"Taurine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D013654","descriptor_name":"Taurine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055502","descriptor_name":"Secondary Prevention","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1038/sj.bjp.0705059","doi":"https://doi.org/10.1038/sj.bjp.0705059","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0705059","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0705059","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1573657","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1573657/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"},{"id":"pmid:12522067","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12522067","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1038/sj.bjp.0705059","doi":"https://doi.org/10.1038/sj.bjp.0705059","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0705059","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0705059","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[{"id":"https://openalex.org/G579444675","display_name":"Taurine Regulation of Alcohol-Seeking Behavior","funder_award_id":"R21AA013276","funder_id":"https://openalex.org/F4320337330","funder_display_name":"National Institute on Alcohol Abuse and Alcoholism"},{"id":"https://openalex.org/G8416825325","display_name":"Control of Ethanol Intake by an mGluR5-PKCe Pathway","funder_award_id":"R01AA013852","funder_id":"https://openalex.org/F4320337330","funder_display_name":"National Institute on Alcohol Abuse and Alcoholism"}],"funders":[{"id":"https://openalex.org/F4320337330","display_name":"National Institute on Alcohol Abuse and Alcoholism","ror":"https://ror.org/02jzrsm59"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2048910098.pdf","grobid_xml":"https://content.openalex.org/works/W2048910098.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W1939011264","https://openalex.org/W1976126176","https://openalex.org/W1977974048","https://openalex.org/W1993776646","https://openalex.org/W2011830495","https://openalex.org/W2013999363","https://openalex.org/W2023409472","https://openalex.org/W2027782928","https://openalex.org/W2033122986","https://openalex.org/W2037444548","https://openalex.org/W2043821740","https://openalex.org/W2052360330","https://openalex.org/W2053863531","https://openalex.org/W2056610139","https://openalex.org/W2063189303","https://openalex.org/W2079275626","https://openalex.org/W2088355418","https://openalex.org/W2094015302","https://openalex.org/W2107071404","https://openalex.org/W2119453026","https://openalex.org/W2132460548","https://openalex.org/W2137886791","https://openalex.org/W2243418101","https://openalex.org/W2313771719"],"related_works":["https://openalex.org/W2089983886","https://openalex.org/W1965895399","https://openalex.org/W4242604250","https://openalex.org/W4238445637","https://openalex.org/W2047137994","https://openalex.org/W1979612890","https://openalex.org/W1982313467","https://openalex.org/W1993776646","https://openalex.org/W2063189303","https://openalex.org/W2023409472"],"abstract_inverted_index":{"The":[0],"effects":[1,13,133],"of":[2,14,31,54,76,91,98,134,139],"the":[3,10,22,52,82,89,96,110,130],"anti-relapse":[4],"compound":[5],"acamprosate":[6,40,113,127],"(calcium":[7],"acetylhomotaurinate)":[8],"on":[9],"conditioned":[11,23,118,131],"rewarding":[12,132],"ethanol,":[15],"cocaine":[16,60,103],"and":[17,71,102,136],"morphine":[18,66],"were":[19,35,86],"studied":[20],"using":[21],"place":[24,119],"preference":[25,120],"(CPP)":[26],"paradigm.":[27],"During":[28],"3":[29],"days":[30],"drug":[32],"conditioning,":[33],"mice":[34,85],"pretreated":[36],"with":[37],"saline":[38],"or":[39,43,65],"(30,":[41],"100":[42],"300":[44],"mg":[45,62,68],"kg(-1)":[46,58,63,69],"i.p.)":[47,64],"10":[48],"min":[49],"prior":[50],"to":[51,74,100],"administration":[53],"ethanol":[55,101,135],"(2":[56],"g":[57],"i.p.),":[59,70],"(15":[61],"(10":[67],"subsequently":[72],"confined":[73],"one":[75],"two":[77],"distinct":[78],"conditioning":[79,111],"chambers.":[80],"On":[81],"following":[83],"day,":[84],"tested":[87,108],"for":[88],"expression":[90],"CPP.":[92],"Acamprosate":[93],"dose-dependently":[94],"reduced":[95],"development":[97],"CPP":[99],"but":[104],"not":[105],"morphine.":[106],"When":[107],"as":[109],"drug,":[112],"alone":[114],"produced":[115],"neither":[116],"a":[117],"nor":[121],"aversion.":[122],"These":[123],"data":[124],"suggest":[125],"that":[126],"can":[128],"suppress":[129],"certain":[137],"classes":[138],"abused":[140],"substances.":[141]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2048910098","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
